International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit
DETROIT, July 20 /PRNewswire-USNewswire/ -- Scientists at the Barbara Ann Karmanos Cancer Institute's National Center for Vermiculite and Asbestos-Related Cancers (NCVAC) have discovered a probable reason for the unrelenting chest pain experienced in certain patients with asbestos-r...
Clinical and Histopathological Results Using Pollogen's TriPollar(TM) Radio Frequency Technology Published in the June Issue of the Journal of Cosmetic and Laser Therapy
TEL AVIV, Israel, June 17 /PRNewswire/ -- A recent clinical study using
Pollogen's regen(TM) device- the latest aesthetic solution powered by 3rd
generation TriPollar(TM) technology, confirms the safety and efficacy of
TriPollar(TM) technology in reducing fat and collagen remodeling. The peer
SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
WASHINGTON, June 7 /PRNewswire/ -- BARI-2D is a useful and focused trial that builds on the body of scientific knowledge physicians use to provide the best possible care for diabetic patients with chronic stable angina and to evaluate their treatment options. The Society for Cardiovascular Angiog...
Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry
- Improvement Was Noted At Day 3 And All Subsequent Study Visits -
FORT LEE, N.J., June 3 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today that positive results from a phase 2 clinical trial for lurasidone in the treatment of patients with schizophrenia have been pu...
Clinical Trial Results of Pollogen's TriPollar(TM) Radio Frequency Technology published in the Journal of the European Academy of Dermatology and Venereology
TEL AVIV, Israel, June 2 /PRNewswire/ -- Clinical trial results using the
regen(TM) system, the newest aesthetic solution powered by 3rd generation
TriPollar RF technology on cellulite treatment and body contouring, have been
published in the online Journal
of the European Academy of Dermatolo...
Study in the New England Journal of Medicine Shows Non-Surgical Treatment for Pre-Cancerous Condition of Esophagus is Effective and Reduces Risk for Cancer Development
Data show superiority of endoscopic ablation therapy using the HALO System for eradicating Barrett's esophagus in randomized, multicenter, sham controlled trial
SUNNYVALE, Calif., May 27 /PRNewswire/ -- Results from a clinical study published today in the New England Journal
of Medicine rev...
Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
Data from landmark trial provide important insight for physicians in treating heart attack patients
NATICK, Mass., May 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed the publication of results from the HORIZONS AMI trial in this week's issue of the New...
Spotlight on Rosacea Advance - May Issue of Journal of Drugs in Dermatology Features Pyratine XR(TM) Clinical Study
- 12-week study concludes that new cosmeceutical improves skin barrier function, erythema and lesions associated with rosacea -
NAPA, Calif., May 4 /PRNewswire-FirstCall/ -- Senetek PLC (OTC Bulletin Board: SNKTY), a life sciences company engaged in the development of technologies that targ...
American Lung Association Study to be Published in the 'New England Journal of Medicine' Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought
--Practice Changing Study Calls on Doctors to Stop Prescribing Potent Heartburn Medications to Asthma Patients Without Frequent Symptoms of Gastric Reflux--
WASHINGTON, April 8 /PRNewswire-USNewswire/ -- For nearly 20 years, it was believed that severe asthma symptoms such as coughing, wheezi...
Landmark Study in The New England Journal of Medicine Shows HPV Testing Significantly Reduces Deaths from Cervical Cancer, Compared to other Methods Including Pap
QIAGEN donates one million tests to expand access to HPV screening in the world's poorest countries
VENLO, Netherlands, April 1 /PRNewswire-FirstCall/ -- Results from an eight-year trial involving more than 130,000 women published today in The New England Journal
of Medicine (NEJM) demonst...
New Study Published in the Journal of Drugs in Dermatology Finds DOT Microablative CO2 Laser Optimum for Skin Rejuvenation
DALLAS, March 5 /PRNewswire/ -- A study published by Deborah S. Sarnoff, M.D. et al in the February issue of the Journal
of Drugs in Dermatology explores the new generation of carbon dioxide (CO2) laser skin resurfacing technologies, specifically, the SmartXide DOT(TM) laser. DOT utilizes a...
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
Data show comparable safety for complex patients treated with TAXUS(R) Express2(TM) Stents and bypass surgery
NATICK, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed the publication of results from its landmark SYNTAX(TM) trial in this week...
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
- Multaq(R) (dronedarone) significantly reduced the risk of cardiovascular hospitalization or death by 24 percent in patients with atrial fibrillation -
PARIS, Feb. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY ) announced today that the...
Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
- Adding Zometa to post-surgery hormone therapy reduced risk of breast cancer return or death by 36% more than hormone therapy alone
- First Phase III data to substantiate anticancer effect of Zometa
- Zometa is the most widely prescribed drug for prevention of bone complications due to ...
Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa
NEW ORLEANS, Dec. 8 /PRNewswire/ -- Results published online today in the
New England Journal
of Medicine revealed that the world's most clinically
advanced malaria vaccine candidate provides both infants and young children
with significant protection against malaria. Two separate phase II trials
Diamyd(R) Study Published in Prestigious New England Journal of Medicine
STOCKHOLM, October 9 /PRNewswire-FirstCall/ -- Diamyd Medical reports
that the world's most influential medical journal, the New England Journal
of Medicine, has published an article with results from the company's study
of the Diamyd(R) diabetes vaccine for type 1 diabetes.
Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
In a clinical study of adults, VYVANSE taken once-daily significantly
improved the symptoms of ADHD within one week
PHILADELPHIA, Oct. 7 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP,
Nasdaq: SHPGY), the global specialty biopharmaceutical company, today
announced that a study published in th...
American Heart Association Journal Report: Miniaturized Heart Pumps May Be Effective for Children Awaiting Transplant
In a small study, miniaturized heart pumps helped keep children alive
who were awaiting a heart transplant.
The devices are not approved for general use in the United States.
DALLAS, Sept. 30 /PRNewswire-USNewswire/ -- In a recent study, nine
pediatric patients with sev...
American Heart Association Journal Report: Surgical Residents Perform Heart Surgery as Effectively as Staff Surgeons
* Success rates, safety and long-term outcomes of heart surgery are not
significantly different when performed by properly supervised surgical
residents or staff surgeons.
* It is safe to include the training of residents even in complex
procedures. It is critical that tr...
New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
- Patients in the VELCADE, melphalan and prednisone arm demonstrated a
significant survival benefit as well as a 30 percent complete response -
CAMBRIDGE, Mass., Aug. 27 /PRNewswire/ -- Millennium: The Takeda
Oncology Company today announced the publication of results from the 682
Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
SEATTLE, Aug. 26 /PRNewswire/ -- Omeros Corporation today announced the
publication of the results from a Phase 1/Phase 2 trial investigating
OMS103HP in arthroscopic anterior cruciate ligament (ACL) reconstruction
surgery. OMS103HP is an investigational drug product that is added to
The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
- Nexavar is First Approved Systemic Therapy to Treat the Disease -
WAYNE, N.J. and EMERYVILLE, Calif., July 23 /PRNewswire-FirstCall/ --
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (Nasdaq:
ONXX) today announced that The New England Journal
of Medicine published
Bioimpedance Spectroscopy is More Accurate and Reliable Than Other Methods of Subclinical Assessment of Lymphedema in Breast Cancer Patients, According to Paper Published in Journal of Clinical Oncology
SAN DIEGO, July 21 /PRNewswire/ -- Bioimpedance spectroscopy (BIS) is
more accurate and reliable than other methods of subclinical assessment of
lymphedema in breast cancer patients, according to a paper published in the
July 20 issue of Journal
of Clinical Oncology (2008; Vol. 26, Issue 21:
Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
ROCHESTER, N.Y., July 17 /PRNewswire-USNewswire/ -- Strong National
Museum of Play is pleased to announce the launch in mid-July of the
of Play, the first interdisciplinary journal
dedicated solely to the study of play.
The inaugural issue enters the scholarly scene...
Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
FRANKLIN, Mass., July 14 /PRNewswire-FirstCall/ -- Echo Therapeutics
(OTC Bulletin Board: ECTE) today announced publication of results from
three pilot clinical studies of its Symphony Transdermal Continuous Glucose
Monitoring (tCGM) System in the Journal
of Diabetes Science and Technology.
Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology
Results are basis for CTI's Marketing Authorization Application currently under review by the EMEA
SEATTLE, July 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)
(Nasdaq: CTIC ; MTA) today announced the publication of results from its
randomized phase III trial ...
Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
HOUSTON, July 1 /PRNewswire/ -- Agennix Incorporated today announced
the publication of final results from a Phase 2 monotherapy trial with
talactoferrin alfa in patients who had failed previous treatment for
advanced or metastatic renal cell carcinoma (RCC). Results from the study,
The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine
First scientific, peer-reviewed publication showing the candidate vaccine induced neutralizing antibodies against widely divergent H5N1 virus
DEERFIELD, Ill., June 11 /PRNewswire-FirstCall/ -- Baxter International
Inc. (NYSE: BAX ) announced publication in the June 12, 2008 issue of The
Biopure Phase III Orthopedic Trial Results Published in Journal of Trauma
CAMBRIDGE, Mass., June 10 /PRNewswire-FirstCall/ -- Biopure Corporation
(Nasdaq: BPUR ) today announced that the results from its Phase III
orthopedic trial (HEM-115) have been published in the June 2008 issue of
of Trauma. This paper is entitled "HBOC-201 as an Alternative
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
Study Demonstrated Efficacy of RELISTOR for Use in Advanced-Illness Patients with Opioid-Induced Constipation
COLLEGEVILLE, Pa. and TARRYTOWN, N.Y., May 28 /PRNewswire-FirstCall/ --
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), and Progenics
Pharmaceuticals, Inc. (N...
Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
PORTLAND, Ore., May 13 /PRNewswire/ -- Dried blood spots are emerging
as a breakthrough alternative to expensive serum collection and transport
for blood tests. In an article published in the March issue of Journal
Diabetes Science and Technology (2008; 2(2):242-3), Ramakrishnan Lakshmy,
Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
- Zingo Demonstrates Quick, Effective Analgesia for Peripheral Venous Access Procedures in Children Three to 18 Years of Age -(1)
SOUTH SAN FRANCISCO, Calif., May 5 /PRNewswire-FirstCall/ -- Anesiva,
Inc. (Nasdaq: ANSV ) announced today the publication of data in Pediatrics,
Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
Data Supports Use of HIV-specific T cell Precursors with High Proliferative Capacity (PHPC) Marker to Predict Reduction of Viral Load
MCLEAN, Va., and BUDAPEST, Hungary, April 21 /PRNewswire/ -- Genetic
Immunity(R), a US/Hungarian clinical-stage company focused on patented
Three Dimensional Visualization of Right Ventricle Provides Important Information for Treatment of Patients with Tetralogy of Fallot, According to a Study in The American Journal of Cardiology
Model Created Using Piecewise Smooth Subdivision Surface Provides Both Shape and Volumetric Evaluation of Tetralogy of Fallot Patients
SEATTLE, April 8, 2008 /PRNewswire/ -- Three dimensional visualization
of the right ventricle provides important shape and volumetric insights
that help ca...
NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
Multiple Clinical Applications for Blood-Derived Stem Cells and Strong Industry Outlook Support NeoStem's Business Model
NEW YORK, Feb. 28 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS ),
which is pioneering the pre-disease collection, processing and long-term
storage of adult...
American Heart Association Journal Report: Reducing Kids' Salt Intake May Lower Soft Drink Consumption, Reducing Obesity, High Blood Pressure and Later Health Risks
DALLAS, Feb. 20 /PRNewswire-USNewswire/ --- Children who eat less salt
drink fewer sugar-sweetened soft drinks and may significantly lower their
risks for obesity, elevated blood pressure and later-in-life heart attack
and stroke, researchers reported in the print and online issue of
IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
Children's Oncology Group Report Shows the Addition of L-MTP-PE to
Chemotherapy Reduced the Risk of Death by 30% in Osteosarcoma Patients
IRVINE, Calif., Feb. 4 /PRNewswire-FirstCall/ -- IDM Pharma, Inc.
(Nasdaq: IDMI ) today announced the Journal
of Clinical Oncology (JCO) has
Clinical Trial Participation Unaffected by Disclosure of Investigator's Financial Stake, Food and Drug Law Journal Article Finds
WASHINGTON, Dec. 18 /PRNewswire-USNewswire/ -- The willingness to
participate in a clinical investigation of a new drug or device is not
affected by the investigator's financial stake in the outcome of the trial,
concludes a new study reported in an article in the latest issue of the
Food and ...
Study of Pathwork Diagnostics' Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
SUNNYVALE, Calif., Dec. 14 /PRNewswire/ -- Pathwork Diagnostics, a
genomics-based diagnostics company focused on oncology, announced that its
Pathwork(R) Tissue of Origin Test is the focus of a study published in the
January issue of The Journal
of Molecular Diagnostics. Pathwork's
Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
SAN MATEO, Calif., Dec. 12 /PRNewswire-FirstCall/ -- BioForm Medical,
Inc. (Nasdaq: BFRM ) today announced the publication of a multi-center,
randomized, blinded comparative study of nasolabial fold treatments
reporting higher patient satisfaction with its Radiesse(R) dermal filler